ED
XPH icon

Exane Derivatives’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Exane Derivatives’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$49 – 758
2018
Q3 		$49 Hold
1
– – ﹤0.01% 644
2018
Q2 		$43 Hold
1
– – ﹤0.01% 643
2018
Q1 		$41 Sell
1
-3,626
-100% -$158K ﹤0.01% 577
2017
Q4 		$158K Buy
3,627
+793
+28% +$33.7K 0.03% 255
2017
Q3 		$121K Sell
2,834
-718
-20% -$30.4K 0.03% 238
2017
Q2 		$153K Buy
+3,552
New +$150K 0.04% 224
2017
Q1 		– Sell
-3,649
Closed -$143K – 700
2016
Q4 		$143K Buy
3,649
+1,902
+109% +$77.4K 0.03% 219
2016
Q3 		$77.2K Buy
+1,747
New +$79.3K 0.01% 258

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $152B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return